查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1401872

到 2030 年神經生理學器材和設備的全球市場預測：按模式、技術、應用、最終用戶和地區進行分析

Neurophysiology Devices and Equipment Market Forecasts to 2030 - Global Analysis By Modality, Technology, Application, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2023年全球神經生理學儀器和設備市場規模為15.2億美元，預計到2030年將達到29.5億美元，預測期內複合年成長率為9.9%。

神經生理學設備和儀器是一大類醫療設備和工具，旨在測量、監測、刺激和記錄神經系統內的電活動和反應。這些設備用於各種臨床、研究和診斷應用，以評估和了解大腦、脊髓、神經和肌肉的功能。

據美國國家腦腫瘤協會稱，到 2021 年，美國將有大約 83,570 人患有腦腫瘤。

神經系統疾病盛行率上升

全球癲癇、阿茲海默症、阿茲海默症和中風等神經系統疾病的盛行率不斷上升，增加了對先進診斷和監測設備的需求。神經生理學設備對於及時識別、準確診斷和持續監測各種狀況至關重要。這些設備使醫療保健專業人員能夠評估神經反應、肌肉功能和大腦活動，有助於做出準確的診斷和個人化治療計劃。此外，神經系統疾病的盛行率不斷增加，需要有效且可靠的神經生理學設備來改善患者管理。這正在推動產業研究、創新和開發最尖端科技，以滿足醫療保健中神經系統疾病不斷成長的需求。

高成本

先進的神經生理學設備，例如腦電圖、腦磁圖和肌電圖系統，通常需要大量的初始投資，以及持續的維護、升級和培訓成本。這些高昂的成本限制了小型診所、預算有限的醫療機構或資源有限的地區獲得最先進的設備。醫療保健工作者操作這些設備和解釋資料的專門培訓成本進一步加劇了財務負擔。因此，對市場拓展的需求正在減少。

整合人工智慧和資料分析

人工智慧主導的演算法和資料分析可以對腦電圖、腦磁圖和肌電圖系統等設備捕獲的複雜神經訊號進行高階處理、解釋和提取有意義的見解。人工智慧演算法促進模式識別、異常檢測和預測建模，以提高神經系統疾病診斷、追蹤和治療計劃的準確性。此外，這種整合將增加神經生理學設備的力量和價值，促進創新，並為更有效的資料處理、即時回饋和更好的決策提供機會，以改善臨床神經病學和神經科學。

複雜性和培訓

先進的神經生理學儀器和設備，如腦電圖和腦磁圖系統的操作很複雜，需要專門的訓練才能有效使用。解釋複雜的神經訊號需要專業知識，而缺乏熟練處理這些設備的專家是一個挑戰。需要全面的培訓計劃以及對醫療保健負責人進行有關這些複雜技術的教育的時間投入可能會成為障礙，限制臨床實踐中的普及和最佳使用，從而阻礙市場成長。

COVID-19 的影響

COVID-19 的爆發對神經生理學器材與設備市場產生了多方面的影響。在大流行的早期階段，由於資源重新分配、門診量減少和擇期手術取消，醫院和診所在提供常規護理方面面臨限制。全球醫療保健系統的經濟景氣衰退和預算限制影響了資本支出，可能會減緩對新神經生理學設備的投資。這導致用於非緊急情況的神經生理學設備的引進暫時減少。儘管面臨挑戰，這場流行病加速了遠端技術的創新，並促進了方便用戶使用且可遠端存取的神經生理學設備和軟體的開發。

腦電圖（EEG）領域預計將在預測期內達到最大

腦電圖（EEG）領域估計佔據最大佔有率。腦電圖 (EEG) 是一種使用放置在頭皮上的小金屬盤（電極）來測量大腦電活動的測試。腦電圖機捕捉腦波模式，可以幫助診斷各種神經系統疾病，包括癲癇、睡眠障礙和腦損傷。腦電圖技術的進步導致了攜帶式、無線、高解析度系統的出現，可實現即時監測和分析。腦電圖在臨床神經病學、神經回饋治療和研究中發揮著重要作用，推動了神經生理學設備市場的持續創新和普及。

醫院部門預計在預測期內複合年成長率最高

預計醫院業務在預測期內將出現良好成長。醫院在神經科、加護病房(ICU) 和神經外科等科室使用各種神經生理學設備進行診斷、監測和治療。在醫院，神經生理學設備有助於診斷癲癇、中風、腦腫瘤和神經肌肉疾病。這些設備包括腦電圖 (EEG)、肌電圖 (EMG)、腦磁圖 (MEG) 以及 MRI 和 CT 掃描儀等神經影像系統。在醫院領域，對準確性、可靠性和創新功能的重視，以改善神經評估和治療中的患者照護和臨床結果，正在推動對先進神經生理學設備的需求。

佔有率最大的地區

由於醫療保健支出增加、神經系統疾病盛行率上升以及醫療保健基礎設施的進步，亞太地區在預測期內佔據了最大的市場佔有率。中國、印度、日本和韓國等國家的大量患者和不斷增加的醫療保健投資在這一擴張中發揮關鍵作用。此外，亞太地區由於與國際製造商的合作夥伴關係以及對研發的重視，為神經生理學器材與設備市場的擴大做出了重大貢獻。

複合年成長率最高的地區：

由於強大的醫療基礎設施和技術進步，預計北美在預測期內將實現盈利成長。該地區建立了研究和醫療機構，促進了技術創新和先進神經生理學設備的採用。在美國和加拿大等國家，用於診斷神經系統疾病的腦電圖、肌電圖和神經影像設備的需求很高。此外，神經系統疾病的日益普及、人口高齡化以及對個人化醫療的重視，都有助於該地區在北美神經生理學技術的採用和市場擴張方面處於領先地位。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球神經生理學器材與設備市場：按方式

  • 攜帶的
  • 獨立的

第6章全球神經生理學器材與設備市場：依技術分類

  • 肌電圖（EMG）
  • 皮質電圖（ECoG）
  • 腦電圖（EEG）
  • 誘發電位 (EP)
  • 其他技術

第7章全球神經生理學器材與設備市場：按應用

  • 睡眠失調
  • 帕金森氏症
  • 癲癇
  • 阿茲海默症
  • 其他用途

第8章全球神經生理學器材與設備市場：按最終用戶分類

  • 門診手術中心
  • 醫院
  • 其他最終用戶

第9章全球神經生理學器材與設備市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章 公司簡介

  • Medtronic PLC.
  • Dr. Langer Medical Gmbh
  • Nihon Kohden Corporation
  • Natus Medical Incorporated
  • NuVasiveInc.
  • Inomed Medizintechnik
  • Axon Healthcare Ltd.
  • Neurosign
  • Bovie Medical Corporation
  • Neurowave Systems
  • Koninklijke Philips NV
  • Cadwell Industries, Inc.
  • Electrical Geodesics Incorporated
  • Advanced Brain Monitoring, Inc.
Product Code: SMRC24392

According to Stratistics MRC, the Global Neurophysiology Devices and Equipment Market is accounted for $1.52 billion in 2023 and is expected to reach $2.95 billion by 2030 growing at a CAGR of 9.9% during the forecast period. Neurophysiology devices and equipment are a broad category of medical instruments and tools designed to measure, monitor, stimulate, or record the electrical activity and responses within the nervous system. These devices are utilised in various clinical, research, and diagnostic applications to assess and understand the functioning of the brain, spinal cord, nerves, and muscles.

According to the National Brain Tumour Society, approximately 83,570 persons in the United States will be affected by Brain Tumours in 2021.

Market Dynamics:

Driver:

Rising prevalence of neurological disorders

The increasing prevalence of neurological disorders such as epilepsy, Parkinson's, Alzheimer's, and stroke worldwide has led to a greater need for sophisticated diagnostic instruments and monitoring apparatus. Neurophysiology equipment is essential for the timely identification, precise diagnosis, and ongoing surveillance of various conditions. They make it possible for medical practitioners to evaluate neural responses, muscle function, and brain activity, which helps with accurate diagnosis and individualised treatment plans. Moreover, the growing prevalence of neurological diseases makes effective and dependable neurophysiology devices necessary for improved patient management. This is propelling the industry's research, innovation, and development of cutting-edge technologies to meet the expanding demands of neurological conditions in healthcare.

Restraint:

High cost

Advanced neurophysiology devices, such as EEG, MEG, and EMG systems, often require substantial initial investments, coupled with ongoing expenses for maintenance, upgrades, and training. These elevated costs limit access to state-of-the-art equipment for smaller clinics, healthcare facilities with limited budgets, or regions with constrained resources. Also, the expense of specialised training for healthcare professionals to operate and interpret data from these devices further adds to the financial burden. Thus, there is a decreasing demand for market expansion.

Opportunity:

Integration of AI and data analytics

AI-driven algorithms and data analytics enable advanced processing, interpretation, and extraction of meaningful insights from complex neural signals captured by devices like EEG, MEG, and EMG systems. Pattern identification, anomaly detection, and predictive modelling are made easier by AI algorithms, which improve the precision of neurological disease diagnosis, tracking, and treatment planning. Moreover, this integration enhances the capabilities and value of neurophysiology equipment, promotes innovation, and enhances clinical neurology and neuroscience by providing opportunities for more effective data processing, real-time feedback, and better decision-making.

Threat:

Complexity and training

The complexity of operating sophisticated neurophysiology devices and equipment, such as EEG or MEG systems, requires specialised training for effective use. Interpretation of complex neural signals demands expertise, posing a challenge due to a shortage of skilled professionals proficient in handling these devices. The need for comprehensive training programmes and the time investment to educate healthcare personnel about these intricate technologies create a barrier, potentially limiting their widespread adoption and optimal utilisation in clinical settings, thereby hindering market growth.

COVID-19 Impact

The COVID-19 pandemic has had a multifaceted impact on the neurophysiology devices and equipment market. During the initial phases of the pandemic, hospitals and clinics faced constraints in providing routine care due to resource reallocation, reduced outpatient visits, and elective procedure cancellations. Economic downturns and budget constraints in healthcare systems globally affected capital expenditure, potentially slowing down investments in new neurophysiology equipment. This led to a temporary decline in the adoption of neurophysiology devices for non-urgent cases. Despite challenges, the pandemic accelerated innovation in remote technologies, fostering the development of user-friendly, remote-accessible neurophysiology devices and software.

The Electroencephalography (EEG) segment is expected to be the largest during the forecast period

The Electroencephalography (EEG) segment is estimated to hold the largest share. An electroencephalogram (EEG) is a test that measures electrical activity in the brain using small metal discs (electrodes) attached to the scalp. EEG devices capture brainwave patterns, aiding in the diagnosis of various neurological conditions such as epilepsy, sleep disorders, and brain injuries. Advancements in EEG technology have led to portable, wireless, and high-resolution systems, enabling real-time monitoring and analysis. EEG plays a crucial role in clinical neurology, neurofeedback therapies, and research, driving continuous innovation and adoption in the market for neurophysiology devices.

The Hospitals segment is expected to have the highest CAGR during the forecast period

The Hospitals segment is anticipated to have lucrative growth during the forecast period. Hospitals utilise various neurophysiology devices for diagnostics, monitoring, and treatment purposes in neurology departments, intensive care units (ICUs), and neurosurgery units. In hospitals, neurophysiology equipment aids in diagnosing epilepsy, stroke, brain tumours, and neuromuscular disorders. These devices include electroencephalography (EEG), electromyography (EMG), magnetoencephalography (MEG), and neuroimaging systems like MRI and CT scanners. The hospital segment drives significant demand for advanced neurophysiology equipment, emphasising accuracy, reliability, and innovative features to enhance patient care and clinical outcomes in neurological assessments and treatments.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period due to increasing healthcare expenditure, the rising prevalence of neurological disorders, and advancements in healthcare infrastructure. The significant patient populations and increasing healthcare investments in nations like China, India, Japan, and South Korea play a crucial role in this expansion. Additionally, the Asia-Pacific area makes a substantial contribution to the growing market for neurophysiology devices and equipment due to partnerships with international manufacturers and a focus on research and development.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to robust healthcare infrastructure and technological advancements. The regions well-established research facilities and healthcare institutions fuel innovation and the adoption of advanced neurophysiology devices. Countries like the United States and Canada witness substantial demand for EEG, EMG, and neuroimaging equipment for diagnosing neurological disorders. Moreover, the increasing prevalence of neurological conditions, ageing population, and emphasis on personalised medicine contribute to the region's leadership in neurophysiology technology adoption and market expansion in North America.

Key players in the market:

Some of the key players in the Neurophysiology Devices and Equipment Market include Medtronic PLC., Dr. Langer Medical Gmbh, Nihon Kohden Corporation, Natus Medical Incorporated, NuVasiveInc., Inomed Medizintechnik, Axon Healthcare Ltd., Neurosign, Bovie Medical Corporation, Neurowave Systems, Koninklijke Philips N.V., Cadwell Industries, Inc., Electrical Geodesics Incorporated, and Advanced Brain Monitoring, Inc.

Key Developments:

In December 2022, Natus Medical Incorporated, a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders, has entered into a definitive agreement to acquire Micromed Holding SAS, a global provider of neurophysiology solutions. Exciting combination of product solutions will create a leading neurodiagnostic and neuromonitoring portfolio supported by an organization of knowledgeable and passionate experts.

In October 2022, Nihon Kohden, a U.S. market leader in precision medical products and services, announced the launch of the Smart Cable™ NMT Pod and disposable electrode, allowing clinicians to monitor neuromuscular blockade with confidence. The new device allows clinicians to objectively monitor the patient's depth of paralysis during surgery when a neuromuscular blockade agent (NMBA), either non-depolarizing or depolarizing, is administered to the patient.

Modalities Covered:

  • Portable
  • Standalone

Technologies Covered:

  • Electromyography (EMG)
  • Electrocorticography (ECoG)
  • Electroencephalography (EEG)
  • Evoked potential (EP)
  • Other Technologies

Applications Covered:

  • Sleep Disorders
  • Parkinson's Disease
  • Epilepsy
  • Alzheimer's Disease
  • Other Applications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Neurophysiology Devices and Equipment Market, By Modality

  • 5.1 Introduction
  • 5.2 Portable
  • 5.3 Standalone

6 Global Neurophysiology Devices and Equipment Market, By Technology

  • 6.1 Introduction
  • 6.2 Electromyography (EMG)
  • 6.3 Electrocorticography (ECoG)
  • 6.4 Electroencephalography (EEG)
  • 6.5 Evoked potential (EP)
  • 6.6 Other Technologies

7 Global Neurophysiology Devices and Equipment Market, By Application

  • 7.1 Introduction
  • 7.2 Sleep Disorders
  • 7.3 Parkinson's Disease
  • 7.4 Epilepsy
  • 7.5 Alzheimer's Disease
  • 7.6 Other Applications

8 Global Neurophysiology Devices and Equipment Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Other End Users

9 Global Neurophysiology Devices and Equipment Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Medtronic PLC.
  • 11.2 Dr. Langer Medical Gmbh
  • 11.3 Nihon Kohden Corporation
  • 11.4 Natus Medical Incorporated
  • 11.5 NuVasiveInc.
  • 11.6 Inomed Medizintechnik
  • 11.7 Axon Healthcare Ltd.
  • 11.8 Neurosign
  • 11.9 Bovie Medical Corporation
  • 11.10 Neurowave Systems
  • 11.11 Koninklijke Philips N.V.
  • 11.12 Cadwell Industries, Inc.
  • 11.13 Electrical Geodesics Incorporated
  • 11.14 Advanced Brain Monitoring, Inc.

List of Tables

  • Table 1 Global Neurophysiology Devices and Equipment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 3 Global Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 4 Global Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 5 Global Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 6 Global Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 7 Global Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 8 Global Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 9 Global Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 10 Global Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 11 Global Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 12 Global Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 13 Global Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 14 Global Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 15 Global Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 16 Global Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 17 Global Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 18 Global Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 19 Global Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 20 Global Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 21 North America Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 22 North America Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 23 North America Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 24 North America Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 25 North America Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 26 North America Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 27 North America Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 28 North America Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 29 North America Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 30 North America Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 31 North America Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 32 North America Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 33 North America Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 34 North America Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 35 North America Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 36 North America Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 37 North America Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 38 North America Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 39 North America Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 40 North America Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 41 Europe Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 42 Europe Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 43 Europe Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 44 Europe Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 45 Europe Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 46 Europe Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 47 Europe Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 48 Europe Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 49 Europe Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 50 Europe Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 51 Europe Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 52 Europe Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 53 Europe Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 54 Europe Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 55 Europe Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 56 Europe Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 57 Europe Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 58 Europe Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 59 Europe Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 60 Europe Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 61 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 62 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 63 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 64 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 65 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 66 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 67 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 68 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 69 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 70 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 71 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 72 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 73 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 74 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 75 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 76 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 77 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 78 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 79 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 80 Asia Pacific Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 81 South America Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 82 South America Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 83 South America Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 84 South America Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 85 South America Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 86 South America Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 87 South America Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 88 South America Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 89 South America Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 90 South America Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 91 South America Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 92 South America Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 93 South America Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 94 South America Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 95 South America Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 96 South America Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 South America Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 98 South America Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 99 South America Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 100 South America Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 101 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Country (2021-2030) ($MN)
  • Table 102 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Modality (2021-2030) ($MN)
  • Table 103 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Portable (2021-2030) ($MN)
  • Table 104 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Standalone (2021-2030) ($MN)
  • Table 105 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Technology (2021-2030) ($MN)
  • Table 106 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electromyography (EMG) (2021-2030) ($MN)
  • Table 107 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electrocorticography (ECoG) (2021-2030) ($MN)
  • Table 108 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Electroencephalography (EEG) (2021-2030) ($MN)
  • Table 109 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Evoked potential (EP) (2021-2030) ($MN)
  • Table 110 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 111 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Application (2021-2030) ($MN)
  • Table 112 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Sleep Disorders (2021-2030) ($MN)
  • Table 113 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Parkinson's Disease (2021-2030) ($MN)
  • Table 114 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Epilepsy (2021-2030) ($MN)
  • Table 115 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Alzheimer's Disease (2021-2030) ($MN)
  • Table 116 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 117 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By End User (2021-2030) ($MN)
  • Table 118 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 119 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 120 Middle East & Africa Neurophysiology Devices and Equipment Market Outlook, By Other End Users (2021-2030) ($MN)